相关实验视频

Updated: Jan 11, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

临床影响和青少年初级肝癌的新见解:青少年的梦?

Huidong Guo¹, Xiaojun Chen², Rong Li³

¹The First Affiliated Hospital (First Clinical Medical College) of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.

Journal of hepatocellular carcinoma

|November 13, 2025

概括

这项研究分析了497例青少年原发性肝癌 (PLC) 病例,发现门静脉瘤血栓,晚期和特定实验室异常是儿科肝癌不良结果的关键指标.

科学领域:

在瘤学瘤学.
儿科医学儿科医学
肝病学肝病学是一种肝病学.

背景情况:

青少年原发性肝癌 (PLC) 是罕见的,具有独特的诊断和治疗挑战.
了解临床特征和预后因素对于改善这一群体的治疗结果至关重要.

研究的目的:

为了追溯分析十多年来青少年PLC患者的临床数据.
总结临床特征,诊断方法和预后因素.
为预防,早期诊断和治疗青少年PLC提供指导.

主要方法:

从497名青少年PLC患者 (2014-2024) 的临床数据的回顾性分析.
人口,临床,成像,实验室和病理特征的描述.
单变量和多变量考克斯回归分析以确定预后因素.

主要成果:

肝细胞癌 (HCC) 是最常见的诊断 (94.36%).
确定的主要预后因素包括门静脉瘤血栓,晚期CNLC阶段,高AFP和GGT,以及非手术治疗.
一年,两年和三年生存率分别为45.27%,20.32%和8.45%.

结论:

青少年PLC经常表现出非特异性症状.
门静脉瘤血栓,晚期CNLC,AFP,GGT异常和非手术治疗是整体生存期 (OS) 的独立预后因素.
这些发现强调了青少年PLC早期检测和量身定制的治疗策略的必要性.

关键词:

青少年青少年青少年临床特征临床特征恶性瘤是一种恶性瘤.原发性肝癌是一种肝癌.预后预后预后有关风险因素的风险因素.特殊人口特别人口.

更多相关视频

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

相关概念视频

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...